LC
AGN

Leon Cooperman’s Allergan plc AGN Stock Holding History

Leon Cooperman’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$138M Buy
619,919
+355,826
+135% +$73.7M 1.83% 20
2014
Q1 		$54.4M Buy
+264,093
New +$52.3M 0.72% 54

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
IIS
Ignis Investment Services Edinburgh, United Kingdom $29.9B AUM

Leon Cooperman's AGN Position: Q2 2014 in Review

Leon Cooperman increased its Allergan plc (AGN) stake by 135% in Q2 2014, buying an estimated $73.7M and bringing the position to 619,919 shares worth $138M. The position accounts for 1.83% of the portfolio, ranked #20.

Leon Cooperman first reported a position in AGN in Q1 2014 and has held it in 2 quarters since. 674 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Leon Cooperman held 619,919 shares of Allergan plc worth $138M as of Q2 2014.
  • Leon Cooperman bought 355,826 Allergan plc shares in Q2 2014, an estimated $73.7M.
  • Allergan plc made up 1.83% of Leon Cooperman's portfolio in Q2 2014, its #20 holding.
  • Leon Cooperman first reported a position in Allergan plc in Q1 2014 and has held it in 2 quarters since.
  • 674 funds tracked by Wall St. Rank held Allergan plc as of Q2 2014.

Based on Cooperman Leon G's 13F filing for Q2 2014, filed 14 Aug 2014.